The DOI matches its Crossref record; 383 of the 383 references it cites were found in a registry or an index.
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
Abstract
Radiometals possess an exceptional breadth of decay properties and have been applied to medicine with great success for several decades. The majority of current clinical use involves diagnostic procedures, which use either positron-emission tomography (PET) or single-photon imaging to detect anatomic abnormalities that are difficult to visualize using conventional imaging techniques (e.g., MRI and X-ray). The potential of therapeutic radiometals has more recently been realized and relies on ionizing radiation to induce irreversible DNA damage, resulting in cell death. In both cases, radiopharmaceutical development has been largely geared toward the field of oncology; thus, selective tumor targeting is often essential for efficacious drug use. To this end, the rational design of four-component radiopharmaceuticals has become popularized. This Review introduces fundamental concepts of drug design and applications, with particular emphasis on bifunctional chelators (BFCs), which ensure secure consolidation of the radiometal and targeting vector and are integral for optimal drug performance. Also presented are detailed accounts of production, chelation chemistry, and biological use of selected main group and rare earth radiometals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shannon, R. D. (1976) · Acta Crystallographica Section A · doi:10.1107/s0567739476001551 · Cited by 66,145
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999) · Chemical Reviews · doi:10.1021/cr980440x · Cited by 4,483
Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors
Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607427 · Cited by 3,308
Hard and soft acids and bases, HSAB, part 1: Fundamental principles
Pearson, R. G. (1968) · Journal of Chemical Education · doi:10.1021/ed045p581 · Cited by 2,511
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Beeby, A., Clarkson, I. M., Dickins, R. S., Faulkner, S., Parker, D., Royle, L., de Sousa, A. S., Williams, J. A. G., & Woods, M. (1999) · Journal of the Chemical Society, Perkin Transactions 2 · doi:10.1039/a808692c · Cited by 1,447
Kratochwil, C., Bruchertseifer, F., Giesel, F. L., Weis, M., Verburg, F. A., Mottaghy, F., Kopka, K., Apostolidis, C., Haberkorn, U., & Morgenstern, A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178673 · Cited by 1,100
Hard and soft acids and bases, HSAB, part II: Underlying theories
Pearson, R. G. (1968) · Journal of Chemical Education · doi:10.1021/ed045p643 · Cited by 1,063
Matching chelators to radiometals for radiopharmaceuticals
Price, E. W., & Orvig, C. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60304k · Cited by 1,018
Self-citationWadas, T. J., Wong, E. H., Weisman, G. R., & Anderson, C. J. (2010) · Chemical Reviews · doi:10.1021/cr900325h · Cited by 924
Afshar-Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Hadaschik, B. A., Holland-Letz, T., Giesel, F. L., Kratochwil, C., Haufe, S., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2298-2 · Cited by 915
Lanthanide and Actinide Chemistry
Cotton, S. (2006) · Wiley eBooks · doi:10.1002/0470010088 · Cited by 901
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Eder, M., Schäfer, M., Bauder-Wüst, U., Hull, W.-E., Wängler, C., Mier, W., Haberkorn, U., & Eisenhut, M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200279b · Cited by 843
PET versus SPECT: strengths, limitations and challenges
Rahmim, A., & Zaidi, H. (2008) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3282f3a515 · Cited by 834
Rahbar, K., Ahmadzadehfar, H., Kratochwil, C., Haberkorn, U., Schäfers, M., Essler, M., Baum, R. P., Kulkarni, H. R., Schmidt, M., Drzezga, A., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.183194 · Cited by 832
Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
Chari, R. V. J. (2008) · Accounts of Chemical Research · doi:10.1021/ar700108g · Cited by 815
Metal Complexes in Aqueous Solutions
Martell, A. E., & Hancock, R. D. (1996) · Springer eBooks · doi:10.1007/978-1-4899-1486-6 · Cited by 707
Smith, R. M., & Martell, A. E. (1989) · Springer eBooks · doi:10.1007/978-1-4615-6764-6 · Cited by 691
The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein
Vermeer, A. W. P., & Norde, W. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76602-1 · Cited by 666
Kratochwil, C., Giesel, F. L., Stefanova, M., Benešová, M., Bronzel, M., Afshar-Oromieh, A., Mier, W., Eder, M., Kopka, K., & Haberkorn, U. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.171397 · Cited by 636
Benešová, M., Schäfer, M., Bauder-Wüst, U., Afshar-Oromieh, A., Kratochwil, C., Mier, W., Haberkorn, U., Kopka, K., & Eder, M. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.147413 · Cited by 612
Chiral Toxicology: It's the Same Thing…Only Different
Smith, S. W. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp097 · Cited by 602
Weineisen, M., Schottelius, M., Simecek, J., Baum, R. P., Yildiz, A., Beykan, S., Kulkarni, H. R., Lassmann, M., Klette, I., Eiber, M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.158550 · Cited by 532
Gadolinium(iii) complexes as MRI contrast agents: ligand design and properties of the complexes
Hermann, P., Kotek, J., Kubíček, V., & Lukeš, I. (2008) · Dalton Transactions · doi:10.1039/b719704g · Cited by 530
Baum, R. P., Kulkarni, H. R., Schuchardt, C., Singh, A., Wirtz, M., Wiessalla, S., Schottelius, M., Mueller, D., Klette, I., & Wester, H.-J. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168443 · Cited by 525
Bander, N. H., Milowsky, M. I., Nanus, D. M., Kostakoglu, L., Vallabhajosula, S., & Goldsmith, S. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.160 · Cited by 509
Kratochwil, C., Bruchertseifer, F., Rathke, H., Bronzel, M., Apostolidis, C., Weichert, W., Haberkorn, U., Giesel, F. L., & Morgenstern, A. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191395 · Cited by 505
Tumor therapy with targeted atomic nanogenerators.
McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501
Targeted α particle immunotherapy for myeloid leukemia
Jurcic, J. G., Larson, S. M., Sgouros, G., McDevitt, M. R., Finn, R. D., Divgi, C. R., Ballangrud, Å. M., Hamacher, K. A., Ma, D., Humm, J. L., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1233.h81602001233_1233_1239 · Cited by 472
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P., Konijnenberg, M. W., Srinivasan, A., Erion, J. L., Schmidt, M. A., Bugaj, J. L., de Jong, M., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100574 · Cited by 471
Bodei, L., Kidd, M., Paganelli, G., Grana, C. M., Drozdov, I., Cremonesi, M., Lepensky, C., Kwekkeboom, D. J., Baum, R. P., Krenning, E. P., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2893-5 · Cited by 465
Bodei, L., Cremonesi, M., Ferrari, M., Pacifici, M., Grana, C. M., Bartolomei, M., Baio, S. M., Sansovini, M., & Paganelli, G. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0778-1 · Cited by 428
Afshar-Oromieh, A., Hetzheim, H., Kratochwil, C., Benesova, M., Eder, M., Neels, O. C., Eisenhut, M., Kübler, W., Holland-Letz, T., Giesel, F. L., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161299 · Cited by 427
Tagawa, S. T., Milowsky, M. I., Morris, M., Vallabhajosula, S., Christos, P., Akhtar, N. H., Osborne, J., Goldsmith, S. J., Larson, S., Taskar, N. P., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0231 · Cited by 427
Kratochwil, C., Bruchertseifer, F., Rathke, H., Hohenfellner, M., Giesel, F. L., Haberkorn, U., & Morgenstern, A. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.203539 · Cited by 421
Kratochwil, C., Giesel, F. L., Bruchertseifer, F., Mier, W., Apostolidis, C., Boll, R., Murphy, K., Haberkorn, U., & Morgenstern, A. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2857-9 · Cited by 407
Radiometals for Combined Imaging and Therapy
Cutler, C. S., Hennkens, H. M., Sisay, N., Huclier-Markai, S., & Jurisson, S. S. (2013) · Chemical Reviews · doi:10.1021/cr3003104 · Cited by 395
Physics of pure and non-pure positron emitters for PET: a review and a discussion
Conti, M., & Eriksson, L. (2016) · EJNMMI Physics · doi:10.1186/s40658-016-0144-5 · Cited by 393
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
Dash, A., Pillai, M. R. A., & Knapp, F. F. (2015) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-014-0315-z · Cited by 386
Eder, M., Neels, O., Müller, M., Bauder-Wüst, U., Remde, Y., Schäfer, M., Hennrich, U., Eisenhut, M., Afshar-Oromieh, A., Haberkorn, U., et al. (2014) · Pharmaceuticals · doi:10.3390/ph7070779 · Cited by 370
Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals
Liu, S., & Edwards, D. S. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000070v · Cited by 351
Prospective of 68Ga-Radiopharmaceutical Development
Velikyan, I. (2014) · Theranostics · doi:10.7150/thno.7447 · Cited by 336
A fully automated flow-based approach for accelerated peptide synthesis
Mijalis, A. J., Thomas, D. A., Simon, M. D., Adamo, A., Beaumont, R., Jensen, K. F., & Pentelute, B. L. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2318 · Cited by 329
Bakker, W. H., Albert, R., Bruns, C., Breeman, W. A. P., Hofland, L. J., Marbach, P., Pless, J., Pralet, D., Stolz, B., Koper, J. W., et al. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90052-d · Cited by 328
Delker, A., Fendler, W. P., Kratochwil, C., Brunegraf, A., Gosewisch, A., Gildehaus, F. J., Tritschler, S., Stief, C. G., Kopka, K., Haberkorn, U., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3174-7 · Cited by 322
Banerjee, S., Pillai, M. R. A., & Knapp, F. F. (. (2015) · Chemical Reviews · doi:10.1021/cr500171e · Cited by 321
Tumour targeting with radiolabelled macrocycle–antibody conjugates
Parker, D. (1990) · Chem. Soc. Rev. · doi:10.1039/cs9901900271 · Cited by 319
Contribution of Variable Domains to the Stability of Humanized IgG1 Monoclonal Antibodies
Ionescu, R. M., Vlasak, J., Price, C., & Kirchmeier, M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21104 · Cited by 313
Baum, R. P., Prasad, V., Müller, D., Schuchardt, C., Orlova, A., Wennborg, A., Tolmachev, V., & Feldwisch, J. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.073239 · Cited by 308
Review: Lanthanide coordination chemistry: from old concepts to coordination polymers
Bünzli, J.-C. G. (2014) · Journal of Coordination Chemistry · doi:10.1080/00958972.2014.957201 · Cited by 306
Therapeutic Radionuclides: Biophysical and Radiobiologic Principles
Kassis, A. I. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.05.002 · Cited by 306
Emmett, L., Willowson, K., Violet, J., Shin, J., Blanksby, A., & Lee, J. (2017) · Journal of Medical Radiation Sciences · doi:10.1002/jmrs.227 · Cited by 305
Luminescence energy transfer using a terbium chelate: improvements on fluorescence energy transfer.
Selvin, P. R., & Hearst, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.10024 · Cited by 299
Radioactive Transition Metals for Imaging and Therapy
Boros, E., & Packard, A. B. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00281 · Cited by 299
Ahmadzadehfar, H., Rahbar, K., Kürpig, S., Bögemann, M., Claesener, M., Eppard, E., Gärtner, F., Rogenhofer, S., Schäfers, M., & Essler, M. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0114-2 · Cited by 293
An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy
Thiele, N. A., Brown, V., Kelly, J. M., Amor‐Coarasa, A., Jermilova, U., MacMillan, S. N., Nikolopoulou, A., Ponnala, S., Ramogida, C. F., Robertson, A. K. H., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201709532 · Cited by 288
Ahmadzadehfar, H., Eppard, E., Kürpig, S., Fimmers, R., Yordanova, A., Schlenkhoff, C. D., Gärtner, F., Rogenhofer, S., & Essler, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7245 · Cited by 282
Coordination chemistry of metals in medicine: target sites for bismuth
Sadler, P. J., Li, H., & Sun, H. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(99)00018-1 · Cited by 280
Kumar, K., Chang, C. A., Francesconi, L. C., Dischino, D. D., Malley, M. F., Gougoutas, J. Z., & Tweedle, M. F. (1994) · Inorganic Chemistry · doi:10.1021/ic00094a021 · Cited by 280
An overview of targeted alpha therapy
Kim, Y.-S., & Brechbiel, M. W. (2012) · Tumor Biology · doi:10.1007/s13277-011-0286-y · Cited by 278
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Anderson, C. J., Dehdashti, F., Cutler, P. D., Schwarz, S. W., Laforest, R. A., Bass, L. A., Lewis, J. S., & Mccarthy, D. W. (2001) · PubMed · Cited by 273
Rosenblat, T. L., McDevitt, M. R., Mulford, D. A., Pandit-Taskar, N., Divgi, C. R., Panageas, K. S., Heaney, M. L., Chanel, S., Morgenstern, A., Sgouros, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0382 · Cited by 271
Müller, C., Zhernosekov, K., Köster, U., Johnston, K., Dorrer, H., Hohn, A., van der Walt, N. T., Türler, A., & Schibli, R. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.107540 · Cited by 271
Chang, C. A., Francesconi, L. C., Malley, M. F., Kumar, K., Gougoutas, J. Z., Tweedle, M. F., Lee, D. W., & Wilson, L. J. (1993) · Inorganic Chemistry · doi:10.1021/ic00068a020 · Cited by 264
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
McDevitt, M. R., Barendswaard, E., Ma, D., Lai, L. T., Curcio, M. J., Sgouros, G., Ballangrud, Å., Yang, W., Finn, R. D., Pellegrini, V., et al. (2000) · PubMed · Cited by 259
Sörensen, J., Sandberg, D., Sandström, M., Wennborg, A., Feldwisch, J., Tolmachev, V., Åström, G., Lubberink, M., Garske-Román, U., Carlsson, J., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.131243 · Cited by 258
68Ga-Based Radiopharmaceuticals: Production and Application Relationship
Velikyan, I. (2015) · Molecules · doi:10.3390/molecules200712913 · Cited by 255
Tumour targeting with radiometals for diagnosis and therapy
Ramogida, C. F., & Orvig, C. (2013) · Chemical Communications · doi:10.1039/c3cc41554f · Cited by 255
Self-citationGarske-Román, U., Sandström, M., Fröss Baron, K., Lundin, L., Hellman, P., Welin, S., Johansson, S., Khan, T., Lundqvist, H., Eriksson, B., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3945-z · Cited by 254
Hofman, M. S., Kong, G., Neels, O. C., Eu, P., Hong, E., & Hicks, R. J. (2012) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1754-9485.2011.02327.x · Cited by 251
A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?
De Kruijff, R., Wolterbeek, H., & Denkova, A. (2015) · Pharmaceuticals · doi:10.3390/ph8020321 · Cited by 249
Luminescence Properties of Self-Aggregating TbIII-DOTA-Functionalized Calix[4]arenes
Mayer, F., Tiruvadi Krishnan, S., Schühle, D. T., Eliseeva, S. V., Petoud, S., Tóth, É., & Djanashvili, K. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00001 · Cited by 249
Wang, S., Lee, R. J., Mathias, C. J., Green, M. A., & Low, P. S. (1996) · Bioconjugate Chemistry · doi:10.1021/bc9500709 · Cited by 245
Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view
Boswell, C. A., & Brechbiel, M. W. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.04.001 · Cited by 241
Kunikowska, J., Królicki, L., Hubalewska-Dydejczyk, A., Mikołajczak, R., Sowa-Staszczak, A., & Pawlak, D. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1833-x · Cited by 238
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
Ambrosini, V., Campana, D., Bodei, L., Nanni, C., Castellucci, P., Allegri, V., Montini, G. C., Tomassetti, P., Paganelli, G., & Fanti, S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.071712 · Cited by 232
Clarke, E. T., & Martell, A. E. (1991) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)80229-7 · Cited by 229
Benešová, M., Bauder-Wüst, U., Schäfer, M., Klika, K. D., Mier, W., Haberkorn, U., Kopka, K., & Eder, M. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01210 · Cited by 228
Ilan, E., Sandström, M., Wassberg, C., Sundin, A., Garske–Román, U., Eriksson, B., Granberg, D., & Lubberink, M. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.148437 · Cited by 227
Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight
Coenen, H. H., Gee, A. D., Adam, M., Antoni, G., Cutler, C. S., Fujibayashi, Y., Jeong, J. M., Mach, R. H., Mindt, T. L., Pike, V. W., et al. (2017) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2017.09.004 · Cited by 226
Design and synthesis of 225Ac radioimmunopharmaceuticals.
McDevitt, M. R., Ma, D., Simon, J., Frank, R. K., & Scheinberg, D. A. (2002) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00167-7 · Cited by 225
Production of Ac-225 from Th-229 for Targeted α Therapy
Apostolidis, C., Molinet, R., Rasmussen, G., & Morgenstern, A. (2005) · Analytical Chemistry · doi:10.1021/ac0580114 · Cited by 215
Müller, C., Bunka, M., Haller, S., Köster, U., Groehn, V., Bernhardt, P., van der Meulen, N., Türler, A., & Schibli, R. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.141614 · Cited by 214
Eisenwiener, K.-P., Prata, M. I. M., Buschmann, I., Zhang, H.-W., Santos, A. C., Wenger, S., Reubi, J. C., & Mäcke, H. R. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010074f · Cited by 213
Miederer, M., Scheinberg, D. A., & McDevitt, M. R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.009 · Cited by 210
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Sundlöv, A., Sjögreen-Gleisner, K., Svensson, J., Ljungberg, M., Olsson, T., Bernhardt, P., & Tennvall, J. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3678-4 · Cited by 209
Kabasakal, L., AbuQbeitah, M., Aygün, A., Yeyin, N., Ocak, M., Demirci, E., & Toklu, T. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3125-3 · Cited by 208
Sgouros, G., Ballangrud, Å., Jurcic, J. G., McDevitt, M. R., Humm, J. L., Erdi, Y. E., Mehta, B. M., Finn, R. D., Larson, S. M., & Scheinberg, D. A. (1999) · PubMed · Cited by 207
Morschhauser, F., Radford, J., Van Hoof, A., Botto, B., Rohatiner, A. Z. S., Salles, G., Soubeyran, P., Tilly, H., Bischof-Delaloye, A., van Putten, W. L. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.6400 · Cited by 206
177Lu-PSMA Radioligand Therapy for Prostate Cancer
Fendler, W. P., Rahbar, K., Herrmann, K., Kratochwil, C., & Eiber, M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191023 · Cited by 206
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Mansi, R., Wang, X., Forrer, F., Waser, B., Cescato, R., Graham, K., Borkowski, S., Reubi, J. C., & Maecke, H. R. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1596-9 · Cited by 205
Perk, L. R., Visser, G. W. M., Vosjan, M. J. W. D., van Walsum, M., Tijink, B. M., Leemans, C. R., & van Dongen, G. A. M. S. (2005) · PubMed · Cited by 205
Hong, H., Zhang, Y., Engle, J. W., Nayak, T. R., Theuer, C. P., Nickles, R. J., Barnhart, T. E., & Cai, W. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.031 · Cited by 204
Cordier, D., Forrer, F., Bruchertseifer, F., Morgenstern, A., Apostolidis, C., Good, S., Müller-Brand, J., Mäcke, H., Reubi, J. C., & Merlo, A. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1385-5 · Cited by 204
Lehenberger, S., Barkhausen, C., Cohrs, S., Fischer, E., Grünberg, J., Hohn, A., Köster, U., Schibli, R., Türler, A., & Zhernosekov, K. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.02.007 · Cited by 200
Umbricht, C. A., Benešová, M., Schmid, R. M., Türler, A., Schibli, R., van der Meulen, N. P., & Müller, C. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0257-4 · Cited by 194
Production logistics of 177Lu for radionuclide therapy
Pillai, M. R. A., Chakraborty, S., Das, T., Venkatesh, M., & Ramamoorthy, N. (2003) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(03)00158-1 · Cited by 191
Qaim, S. M. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.08.016 · Cited by 190
Villard, L., Romer, A., Marincek, N., Brunner, P., Koller, M. T., Schindler, C., Ng, Q. K. T., Mäcke, H. R., Müller-Brand, J., Rochlitz, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2151 · Cited by 189
The synthesis and application of polyamino polycarboxylic bifunctional chelating agents
Lattuada, L., Barge, A., Cravotto, G., Giovenzana, G. B., & Tei, L. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00199f · Cited by 187
Heck, M. M., Retz, M., D'Alessandria, C., Rauscher, I., Scheidhauer, K., Maurer, T., Storz, E., Janssen, F., Schottelius, M., Wester, H.-J., et al. (2016) · Journal of Urology · doi:10.1016/j.juro.2016.02.2969 · Cited by 187
von Eyben, F. E., Roviello, G., Kiljunen, T., Uprimny, C., Virgolini, I., Kairemo, K., & Joensuu, T. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3895-x · Cited by 184
Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
Campana, D., Ambrosini, V., Pezzilli, R., Fanti, S., Labate, A. M. M., Santini, D., Ceccarelli, C., Nori, F., Franchi, R., Corinaldesi, R., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066662 · Cited by 183
First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
Wild, D., Fani, M., Behe, M., Brink, I., Rivier, J. E. F., Reubi, J. C., Maecke, H. R., & Weber, W. A. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.088922 · Cited by 183
Delgado, R., Félix, V., Lima, L. M. P., & Price, D. W. J. (2007) · Dalton Transactions · doi:10.1039/b704360k · Cited by 179
Weineisen, M., Simecek, J., Schottelius, M., Schwaiger, M., & Wester, H.-J. (2014) · EJNMMI Research · doi:10.1186/s13550-014-0063-1 · Cited by 179
Apostolidis, C., Molinet, R., McGinley, J., Abbas, K., Möllenbeck, J., & Morgenstern, A. (2005) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2004.06.013 · Cited by 176
Gallium(III) Complexes of DOTA and DOTA−Monoamide: Kinetic and Thermodynamic Studies
Kubíček, V., Havlíčková, J., Kotek, J., Tircsó, G., Hermann, P., Tóth, É., & Lukeš, I. (2010) · Inorganic Chemistry · doi:10.1021/ic101378s · Cited by 176
Nikula, T. K., McDevitt, M. R., Finn, R. D., Wu, C., Kozak, R. W., Garmestani, K., Brechbiel, M. W., Curcio, M. J., Pippin, C. G., Tiffany-Jones, L., et al. (1999) · PubMed · Cited by 176
Velikyan, I., Sundin, A., Sörensen, J., Lubberink, M., Sandström, M., Garske-Román, U., Lundqvist, H., Granberg, D., & Eriksson, B. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.126177 · Cited by 176
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
Makvandi, M., Dupis, E., Engle, J. W., Nortier, F. M., Fassbender, M. E., Simon, S., Birnbaum, E. R., Atcher, R. W., John, K. D., Rixe, O., et al. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0550-9 · Cited by 173
Production of actinium-225 for alpha particle mediated radioimmunotherapy.
Boll, R. A., Malkemus, D., & Mirzadeh, S. (2005) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2004.12.003 · Cited by 171
Nicolas, G. P., Schreiter, N., Kaul, F., Uiters, J., Bouterfa, H., Kaufmann, J., Erlanger, T. E., Cathomas, R., Christ, E., Fani, M., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.199760 · Cited by 171
Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling
Tsionou, M. I., Knapp, C. E., Foley, C. A., Munteanu, C. R., Cakebread, A., Imberti, C., Eykyn, T. R., Young, J. D., Paterson, B. M., Blower, P. J., et al. (2017) · RSC Adv. · doi:10.1039/c7ra09076e · Cited by 169
Moreau, J., Guillon, E., Pierrard, J., Rimbault, J., Port, M., & Aplincourt, M. (2004) · Chemistry – A European Journal · doi:10.1002/chem.200400006 · Cited by 162
Current status of theranostics in prostate cancer
Virgolini, I. J., Decristoforo, C., Haug, A. R., Fanti, S., & Uprimny, C. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3882-2 · Cited by 161
Hong, S., Hobbs, R. F., Vajravelu, R. K., Huso, D. L., Esaias, C. E., Apostolidis, C., Morgenstern, A., & Sgouros, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1828 · Cited by 158
Eplattenier, F. L., Murase, I., & Martell, A. E. (1967) · Journal of the American Chemical Society · doi:10.1021/ja00980a019 · Cited by 158
Loncin, M. F., Desreux, J. F., & Merciny, E. (1986) · Inorganic Chemistry · doi:10.1021/ic00235a031 · Cited by 157
A nuclear chocolate box: the periodic table of nuclear medicine
Blower, P. J. (2014) · Dalton Transactions · doi:10.1039/c4dt02846e · Cited by 155
Miederer, M., Henriksen, G., Alke, A., Mossbrugger, I., Quintanilla-Martinez, L., Senekowitsch-Schmidtke, R., & Essler, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4647 · Cited by 155
Hindié, E., Zanotti‐Fregonara, P., Quinto, M. A., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170423 · Cited by 152
Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate
Müller, C., Reber, J., Haller, S., Dorrer, H., Bernhardt, P., Zhernosekov, K., Türler, A., & Schibli, R. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2563-z · Cited by 151
Targeted actinium-225 in vivo generators for therapy of ovarian cancer.
Borchardt, P. E., Yuan, R., Miederer, M., McDevitt, M. R., & Scheinberg, D. A. (2003) · PubMed · Cited by 150
Förster, G. J., Engelbach, M., Brockmann, J., Reber, H., Buchholz, H., Mäcke, H. R., Rösch, F., Herzog, H. R., & Bartenstein, P. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100628 · Cited by 149
Nicolas, G. P., Mansi, R., McDougall, L., Kaufmann, J., Bouterfa, H., Wild, D., & Fani, M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191684 · Cited by 149
Crystal structure and solution dynamics of the lutetium(III) chelate of DOTA
Aime, S., Barge, A., Botta, M., Fasano, M., Danilo Ayala, J., & Bombieri, G. (1996) · Inorganica Chimica Acta · doi:10.1016/0020-1693(96)05130-4 · Cited by 148
Sathekge, M. M., Knoesen, O., Meckel, M., Modiselle, M., Vorster, M., & Marx, S. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3657-9 · Cited by 147
Radiotheranostics in Cancer Diagnosis and Management
Jadvar, H., Chen, X. S., Cai, W., & Mahmood, U. (2018) · Radiology · doi:10.1148/radiol.2017170346 · Cited by 146
Herrmann, K., Lapa, C., Wester, H., Schottelius, M., Schiepers, C. W., Eberlein, U., Bluemel, C., Keller, U. B., Knop, S. T., Kropf, S., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.151647 · Cited by 144
Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617
Kratochwil, C., Schmidt, K. F., Afshar‐Oromieh, A., Bruchertseifer, F., Rathke, H. G., Morgenstern, A., Haberkorn, U., & Giesel, F. L. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3817-y · Cited by 142
Majkowska‐Pilip, A., & Bilewicz, A. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.11.003 · Cited by 140
Eppard, E., de la Fuente, A., Benešová, M., Khawar, A., Bundschuh, R. A., Gärtner, F., Kreppel, B., Kopka, K., Essler, M., & Rösch, F. (2017) · Theranostics · doi:10.7150/thno.20586 · Cited by 140
An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation.
McDevitt, M. R., Finn, R. D., Sgouros, G., Ma, D., & Scheinberg, D. A. (1999) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(98)00151-1 · Cited by 138
Wild, D., Frischknecht, M., Zhang, H., Morgenstern, A., Bruchertseifer, F., Boisclair, J., Provencher-Bolliger, A., Reubi, J., & Maëcke, H. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1186 · Cited by 137
Measured Human Dosimetry of 68 Ga-DOTATATE
Walker, R. C., Smith, G. T., Liu, E., Moore, B., Clanton, J. A., & Stabin, M. G. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114165 · Cited by 137
Camera, L., Kinuya, S., Garmestani, K., Wu, C., Brechbiel, M. W., Pai, L. H., McMurry, T. J., Gansow, O. A., Pastan, I. H., & Paik, C. H. (1994) · PubMed · Cited by 137
Backbone-substituted DTPA ligands for yttrium-90 radioimmunotherapy
Brechbiel, M. W., & Gansow, O. A. (1991) · Bioconjugate Chemistry · doi:10.1021/bc00009a008 · Cited by 135
A process for the separation of 177Lu from neutron irradiated 176Yb targets
Horwitz, E. P., McAlister, D. R., Bond, A. H., Barrans, R. E., & Williamson, J. M. (2005) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2005.02.005 · Cited by 134
Helisch, A., F�rster, G., Reber, H., Buchholz, H., Arnold, R., G�ke, B., Weber, M. M., Wiedenmann, B., Pauwels, S. A., Haus, U., et al. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1561-6 · Cited by 133
Improved in vivo stability and tumor targeting of bismuth-labeled antibody.
Ruegg, C. L., Anderson-Berg, W. T., Brechbiel, M. W., Mirzadeh, S., Gansow, O. A., & Strand, M. (1990) · PubMed · Cited by 130
Improved in Vivo Stability of Actinium-225 Macrocyclic Complexes
Deal, K. A., Davis, I. A., Mirzadeh, S., Kennel, S. J., & Brechbiel, M. W. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990141f · Cited by 130
Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy
McLaughlin, M. F., Woodward, J. D., Boll, R. A., Wall, J. S., Rondinone, A. J., Kennel, S. J., Mirzadeh, S., & Robertson, J. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054531 · Cited by 130
The present and future of medical radionuclide production
Qaim, S. M. (2012) · Radiochimica Acta · doi:10.1524/ract.2012.1966 · Cited by 130
Vallabhajosula, S., Goldsmith, S. J., Kostakoğlu, L., Milowsky, M. I., Nanus, D. M., & Bander, N. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1004-0023 · Cited by 130
Vallabhajosula, S., Kuji, I., Hamacher, K. A., Konishi, S., Kostakoğlu, L., Kothari, P. A., Milowsky, M. I., Nanus, D. M., Bander, N. H., & Goldsmith, S. J. (2005) · PubMed · Cited by 130
Imaging of Melanoma Using 64Cu− and 86Y−DOTA−ReCCMSH(Arg11), a Cyclized Peptide Analogue of α-MSH
Mcquade, P. S., Miao, Y., Yoo, J., Quinn, T. P., Welch, M. J., & Lewis, J. S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0490282 · Cited by 129
Zhang, H., Schuhmacher, J., Waser, B., Wild, D., Eisenhut, M., Reubi, J. C., & Maëcke, H. R. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0347-4 · Cited by 128
Schwartz, J., Jaggi, J. S., O’Donoghue, J. A., Ruan, S., McDevitt, M. R., Larson, S. M., Scheinberg, D. A., & Humm, J. L. (2011) · Physics in Medicine and Biology · doi:10.1088/0031-9155/56/3/012 · Cited by 128
Chinol, M., Bodei, L., Cremonesi, M., & Paganelli, G. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31563 · Cited by 127
Behr, T. M., Béhé, M. P., Stabin, M. G., Wehrmann, E., Apostolidis, C., Molinet, R., Strutz, F., Fayyazi, A., Wieland, E., Gratz, S., et al. (1999) · PubMed · Cited by 127
68Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis
Graham, M. M., Gu, X., Ginader, T., Breheny, P. J., & Sunderland, J. J. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191197 · Cited by 124
Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab
Beyer, G. J., Miederer, M., Vranješ‐Đurić, S., Comor, J. J., Künzi, G., Hartley, O., Senekowitsch–Schmidtke, R., Soloviev, D., & Buchegger, F. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1413-9 · Cited by 123
Müller, C., Bunka, M., Reber, J., Fischer, C. R., Zhernosekov, K., Türler, A., & Schibli, R. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123810 · Cited by 123
Spectrophotometric determination of the proton-dependent stability constant of ferric enterobactin
Harris, W. R., Carrano, C. J., & Raymond, K. N. (1979) · Journal of the American Chemical Society · doi:10.1021/ja00502a053 · Cited by 121
Eder, M., Schäfer, M. K.-H., Bauder‐Wüst, U., et al. (2014) · The Prostate · doi:10.1002/pros.22784 · Cited by 120
Cyclotron production of 44Sc: From bench to bedside
van der Meulen, N. P., Bunka, M., Domnanich, K. A., Müller, C., Haller, S., Vermeulen, C. E., Türler, A., & Schibli, R. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.05.005 · Cited by 120
Miederer, M., McDevitt, M. R., Sgouros, G., Kramer, K., Cheung, N. V., & Scheinberg, D. A. (2004) · PubMed · Cited by 119
Griswold, J. R., Medvedev, D., Engle, J. W., Copping, R., Fitzsimmons, J., Radchenko, V., Cooley, J. C., Fassbender, M. E., Denton, D. L., Murphy, K. E., et al. (2016) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2016.09.026 · Cited by 119
H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals
Price, E. W., Cawthray, J. F., Bailey, G. A., Ferreira, C. L., Boros, E., Adam, M. J., & Orvig, C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3024725 · Cited by 116
Self-citation44Sc: An Attractive Isotope for Peptide-Based PET Imaging
Hernandez, R., Valdovinos, H. F., Yang, Y., Chakravarty, R., Hong, H., Barnhart, T. E., & Cai, W. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500343j · Cited by 116
Brechbiel, M. W., & Gansow, O. A. (1992) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19920001173 · Cited by 115
An improved generator for the production of 212Pb and 212Bi from 224Ra
Atcher, R. W., FRIEDMAN, A. M., & Hines, J. J., Jr. (1988) · International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes · doi:10.1016/0883-2889(88)90016-0 · Cited by 114
Abiraj, K., Mansi, R., Tamma, M., Fani, M., Forrer, F., Nicolas, G., Cescato, R., Reubi, J. C., & Maëcke, H. R. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.094375 · Cited by 114
Radchenko, V., Engle, J. W., Wilson, J. J., Maassen, J. R., Nortier, F. M., Taylor, W. A., Birnbaum, E. R., Hudston, L. A., John, K. D., & Fassbender, M. E. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.12.045 · Cited by 113
Baum, R. P., Kluge, A., Kulkarni, H., Schorr-Neufing, U., Niepsch, K., Bitterlich, N., & van Echteld, C. J. A. (2016) · Theranostics · doi:10.7150/thno.13702 · Cited by 113
Champion, C., Quinto, M. A., Morgat, C., Zanotti‐Fregonara, P., & Hindié, E. (2016) · Theranostics · doi:10.7150/thno.15132 · Cited by 113
LaPO4 Nanoparticles Doped with Actinium-225 that Partially Sequester Daughter Radionuclides
Woodward, J. D., Kennel, S. J., Stuckey, A. C., Osborne, D., Wall, J. S., Rondinone, A. J., Standaert, R. F., & Mirzadeh, S. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100574f · Cited by 112
Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.
McDevitt, M. R., Finn, R. D., Ma, D., Larson, S. M., & Scheinberg, D. A. (1999) · PubMed · Cited by 112
Westcott, M. A., Coldwell, D. M., Liu, D. M., & Zikria, J. F. (2016) · Advances in Radiation Oncology · doi:10.1016/j.adro.2016.08.003 · Cited by 112
Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
Yong, K. J., & Brechbiel, M. W. (2011) · Dalton Transactions · doi:10.1039/c0dt01387k · Cited by 111
Milenic, D. E., Garmestani, K., Chappell, L. L., Dadachova, E., Yordanov, A. T., Ma, D., Schlom, J., & Brechbiel, M. W. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00294-9 · Cited by 110
Wu, C., Kobayashi, H., Sun, B., Yoo, T. M., Paik, C. H., Gansow, O. A., Carrasquillo, J. A., Pastan, I. H., & Brechbiel, M. W. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)00130-2 · Cited by 109
Ballangrud, Å., Yang, W.-H., Palm, S., Enmon, R. M., Borchardt, P. E., Pellegrini, V., McDevitt, M. R., Scheinberg, D. A., & Sgouros, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0800 · Cited by 106
Norenberg, J. P., Krenning, B. J., Konings, I. R. H. M., Kusewitt, D. F., Nayak, T. K., Anderson, T. L., de Jong, M., Garmestani, K., Brechbiel, M. W., & Kvols, L. K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1264 · Cited by 105
Equilibrium Constants for the Binding of Indium(III) to Human Serum Transferrin
Harris, W. R., Chen, Y., & Wein, K. (1994) · Inorganic Chemistry · doi:10.1021/ic00100a024 · Cited by 103
Chakravarty, R., Pandey, U., Manolkar, R. B., Dash, A. K., Venkatesh, M., & Pillai, M. R. A. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.10.009 · Cited by 101
Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy
Kolsky, K. L., Joshi, V. N., Mausner, L. F., & Srivastava, S. C. (1998) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(98)00016-5 · Cited by 100
Evaluation of Bifunctional Chelates for the Development of Gallium-Based Radiopharmaceuticals
Ferreira, C. L., Lamsa, E., Woods, M., Duan, Y., Fernando, P., Bensimon, C., Kordos, M., Guenther, K. J., Jurek, P. E., & Kiefer, G. E. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900443a · Cited by 100
Rizzieri, D. A. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.07.008 · Cited by 100
Vojtišek, P., Cígler, P., Kotek, J., Rudovský, J., Hermann, P., & Lukeš, I. (2005) · Inorganic Chemistry · doi:10.1021/ic048190s · Cited by 99
Breaking Chemoresistance and Radioresistance with [213Bi]anti-CD45 Antibodies in Leukemia Cells
Friesen, C., Glatting, G., Koop, B., Schwarz, K., Morgenstern, A., Apostolidis, C., Debatin, K., & Reske, S. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3569 · Cited by 99
Sun, Y., Anderson, C. J., Pajeau, T. S., Reichert, D. E. C., Hancock, R. D., Motekaitis, R. J., Martell, A. E., & Welch, M. J. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9505977 · Cited by 99
Availability of Yttrium-90 from Strontium-90: A Nuclear Medicine Perspective
Chakravarty, R., & Dash, A. K. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1285 · Cited by 98
Ballangrud, Å., Yang, W., Charlton, D. E., McDevitt, M. R., Hamacher, K. A., Panageas, K. S., Ma, D., Bander, N. H., Scheinberg, D. A., & Sgouros, G. (2001) · PubMed · Cited by 98
Radiochemical separation of no-carrier-added as produced via the process
Lebedev, N. A., Novgorodov, A. F., Misiak, R., Brockmann, J., & Rösch, F. (2000) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(99)00284-5 · Cited by 98
Nelson, W. O., Karpishin, T. B., Rettig, S. J., & Orvig, C. (1988) · Inorganic Chemistry · doi:10.1021/ic00279a022 · Cited by 97
Self-citation225Ac and 223Ra production via 800MeV proton irradiation of natural thorium targets
Weidner, J. W., Mashnik, S. G., John, K. D., Ballard, B. D., Birnbaum, E. R., Bitteker, L. J., Couture, A. J., Fassbender, M. E., Goff, G. S., Gritzo, R. E., et al. (2012) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2012.07.003 · Cited by 97
Weidner, J. W., Mashnik, S. G., John, K. D., Hemez, F., Ballard, B. D., Bach, H., Birnbaum, E. R., Bitteker, L. J., Couture, A. J., Dry, D., et al. (2012) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2012.07.006 · Cited by 97
Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers
Sofou, S., Kappel, B. J., Jaggi, J. S., McDevitt, M. R., Scheinberg, D. A., & Sgouros, G. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070075t · Cited by 94
Octadentate Picolinic Acid‐Based Bispidine Ligand for Radiometal Ions
Comba, P., Jermilova, U., Orvig, C., Patrick, B. O., Ramogida, C. F., Rück, K. S. L., Schneider, C., & Starke, M. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201702284 · Cited by 94
Self-citationClinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152 Tb-DOTATOC
Baum, R. P., Singh, A., Benešová, M., Vermeulen, C. E., Gnesin, S., Köster, U., Johnston, K., Müller, D., Senftleben, S., Kulkarni, H., et al. (2017) · Dalton Transactions · doi:10.1039/c7dt01936j · Cited by 94
Aime, S., Barge, A., Benetollo, F., Bombieri, G., Botta, M., & Uggeri, F. (1997) · Inorganic Chemistry · doi:10.1021/ic9704501 · Cited by 93
Maguire, W. F., McDevitt, M. R., Smith-Jones, P. M., & Scheinberg, D. A. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.138347 · Cited by 93
John, A. E., Luckett, J., Tatler, A. L., Awais, R. O., Desai, A., Habgood, A., Ludbrook, S. B., Blanchard, A. D., Perkins, A. C., Jenkins, G. R., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120592 · Cited by 93
Vallabhajosula, S., Goldsmith, S. J., Hamacher, K. A., et al. (2005) · PubMed · Cited by 92
Domnanich, K. A., Müller, C., Benešová, M., Dressler, R., Haller, S., Köster, U., Ponsard, B., Schibli, R., Türler, A., & van der Meulen, N. P. (2017) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-017-0024-x · Cited by 92
Ocean, A. J., Pennington, K. L., Guarino, M. J., Sheikh, A., Bekaii‐Saab, T., Serafini, A. N., Lee, D. C., Sung, M. W., Güleç, S., Goldsmith, S. J., et al. (2012) · Cancer · doi:10.1002/cncr.27592 · Cited by 90
Carrasquillo, J. A., White, J. D., Paik, C. H., Raubitschek, A. A., Le, N., Rotman, M., Brechbiel, M. W., Gansow, O. A., Top, L. E., Perentesis, P., et al. (1999) · PubMed · Cited by 90
Srivastava, S. C. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.12.004 · Cited by 89
Cited by
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Classification of Metal-Based Drugs according to Their Mechanisms of Action
Boros, E., Dyson, P. J., & Gasser, G. (2020) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 437
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations
Filosofov, D., Kurakina, E., & Radchenko, V. (2021) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.12.001 · Cited by 341
Cotruvo, J. A. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00642 · Cited by 317
Radiolabelling of nanomaterials for medical imaging and therapy
Pellico, J., Gawne, P. J., & T. M. de Rosales, R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00384k · Cited by 304
Metadata
- Authors
- Kostelnik, T. I., & Orvig, C.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-10-31
- Volume
- 119
- Issue
- 2
- Pages
- 902-956
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2898883116
- Cited by
- 483
- References
- 383
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.